What is Lotus Eye Hospital And Institute Ltd (LOTUSEYE) share price return in the past 10 years?

Lotus Eye Hospital And Institute Ltd share price has appreciated 22.2% annually (CAGR) over the past ten years.

What is the share price of Lotus Eye Hospital And Institute Ltd (LOTUSEYE)?

Company share prices are keep on changing according to the market conditions. The current trading price of Lotus Eye Hospital And Institute Ltd (LOTUSEYE) on 02-Jul-2026 16:59:59 at 16:59 is 126.50.

What is the P/E ratio of Lotus Eye Hospital And Institute?

The latest standalone P/E ratio of Lotus Eye Hospital And Institute as of 02-Jul-2026 is 3247.82.

What is the P/B ratio of Lotus Eye Hospital And Institute Ltd (LOTUSEYE)?

The latest standalone P/B ratio of Lotus Eye Hospital And Institute Ltd (LOTUSEYE) as of 02-Jul-2026 is 4.37.

What is the 52-week high and low of Lotus Eye Hospital And Institute Ltd (LOTUSEYE)?

The 52-week high of Lotus Eye Hospital And Institute Ltd (LOTUSEYE) is Rs. 153.00 and the 52-week low is Rs. 70.08.

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Lotus Eye Hospital And Institute Ltd (LOTUSEYE)
Brand: Lotus Eye Hospital And Institute

Lotus Eye Hospital And Institute Ltd (LOTUSEYE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532998 NSE: LOTUSEYE Hospital & Healthcare Services | Small Cap | Lotus Eye Hospital Share Price

Lotus Eye Hospital And Institute Ltd (LOTUSEYE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532998 NSE: LOTUSEYE Hospital & Healthcare Services | Small Cap | Lotus Eye Hospital Share Price

Key Metrics

Valuation Multiples

Market Cap

₹263 Cr.

Current Price

₹126.5

52-Week Low / High

₹70 / 153

TTM EPS

₹0

TTM Sales

₹53.7 Cr.

Book Value per Share

₹28.9

P/E Ratio

3247.82

Higher than its 5-year historical median

Industry PE

93.2

Price to Book (P/B)

4.37

Higher than its 5-year historical median

Price to Sales (P/S)

4.90

Higher than its 5-year historical median

EV/EBITDA

59.37

Higher than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

1.24%

Underperforms industry median

Return on Capital Employed (ROCE)

3.10%

Underperforms industry median

Return on Assets (ROA)

1.09%

Operating Profit Margin

7.2%

Net Profit Margin

1.49%

Gross Profit Margin

8.8%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

2.8%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-46.3%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-74.57%

Asset Quality

Promoter Holding

40.14%

Pledged shares (%) of Promoter's holding (%)

87.15%

Reserves

₹39 Cr.

Equity

₹20.8 Cr.

Face Value

₹10

All Time Low / High

₹4.43 / 153.00

Lotus Eye Hospital And Institute stock performance

Key Ratios

Check Before You Invest

Quality

Not Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Lotus Eye Hospital And Institute Ltd a good quality company?

Lotus Eye Hospital And Institute Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Lotus Eye Hospital And Institute Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Lotus Eye Hospital And Institute Ltd vs industry peers?

Lotus Eye Hospital And Institute Ltd revenue CAGR is 4.09%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Lotus Eye Hospital And Institute Ltd?

Promoters hold 40.14% of the Lotus Eye Hospital And Institute Ltd, with 87.15% of their stake pledged, indicating high pledge risk.

Q.1 Valuation ratios of Lotus Eye Hospital And Institute Ltd vs historical?

The current P/E ratio of 336.63 is higher than its historical median of 45.08, indicating that the stock is trading above its historical average valuation.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.3%	1.1%	3.7%	1.7%	3.3%	4.1%	8%	10.4%	7.2%	3.1%	-
Value Creation Index ⓘ	-1.0	-0.9	-0.7	-0.9	-0.8	-0.7	-0.4	-0.3	-0.5	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	31.1	34	38	38.4	40.6	32.4	38.9	47	48.2	49.6	54
Sales YoY Gr.	-	9.1%	12%	1.1%	5.5%	-20.2%	20.2%	20.9%	2.5%	2.8%	-
Adj EPS ⓘ	0.1	0.2	0.8	0.3	0.8	0.7	1.4	2	1.4	0.4	0
YoY Gr.	-	340%	277.3%	-59%	120.6%	-2.7%	97.3%	36.1%	-28.6%	-75%	-
BVPS (₹) ⓘ	23.8	24.1	24.4	24.1	24.7	25.3	26.3	27.7	28.6	28.9	28.9
Adj Net Profit ⓘ	0.1	0.5	1.7	0.7	1.6	1.5	3	4.1	2.9	0.7	0
Cash Flow from Ops. ⓘ	3.4	3	5.8	4.2	5	2.7	4.4	4.4	5.7	2.7	-
Debt/CF from Ops. ⓘ	0.2	0.2	0.1	0.1	0.1	0.1	0	0	0	0.2	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.3%	4.1%	8.4%	2.8%
Adj EPS ⓘ	24.1%	-14.1%	-37.6%	-75%
BVPSⓘ	2.2%	3.2%	3.2%	1%
Share Price	22.2%	20.3%	16.4%	77.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.2	0.9	3.4	1.4	3.1	2.9	5.6	7.3	5	1.2	0.1
Op. Profit Mgn % ⓘ	10.2	9.8	11.5	8.4	9.8	11.2	15.3	16.4	13.8	7.2	6.3
Net Profit Mgn % ⓘ	0.3	1.4	4.5	1.8	3.8	4.7	7.7	8.7	6	1.5	0.2
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0.2
Working Cap Days ⓘ	98	93	96	92	72	88	76	71	79	80	37
Cash Conv. Cycle ⓘ	-1	-1	-9	-7	-6	-9	-12	-7	1	7	9

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	31	34	38	38	41	32	39	47	48	50
Operating Expenses ⓘ +	28	31	34	35	37	29	33	39	42	46
Manufacturing Costs	7	7	9	9	10	8	9	10	11	13
Material Costs	9	11	11	11	12	10	12	15	15	15
Employee Cost	6	7	8	8	8	7	7	9	9	11
Other Costs ⓘ	6	5	6	6	7	4	5	6	6	6
Operating Profit ⓘ	3	3	4	3	4	4	6	8	7	4
Operating Profit Margin (%)	10.2%	9.8%	11.4%	8.4%	9.8%	11.2%	15.2%	16.4%	13.8%	7.2%
Other Income ⓘ +	1	1	1	1	1	1	1	1	1	1
Exceptional Items ⓘ	0	-0	0	-0	-1	0	-0	-0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	4	3	3	3	2	2	3	3	4	3
Profit Before Tax ⓘ	-0	0	2	1	1	2	4	6	4	1
Tax ⓘ	-0	-0	-0	-0	0	0	1	2	1	1
Profit After Tax	0	0	2	1	1	2	3	4	3	1
PAT Margin (%)	0.3%	1.3%	4.6%	1.8%	2.6%	4.8%	7.7%	8.7%	6.1%	1.5%
Adjusted EPS (₹)	0.1	0.2	0.8	0.3	0.5	0.8	1.4	2.0	1.4	0.4
Dividend Payout Ratio (%)	0%	234.20%	59.50%	0%	0%	66.30%	34.80%	25.50%	35.70%	0%

Valuation of Lotus Eye Hospital - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	49	50	51	50	51	53	55	58	59	60
Share Capital ⓘ	21	21	21	21	21	21	21	21	21	21
Reserves ⓘ	29	29	30	29	30	32	34	37	39	39
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	3	3	4	3	3	3	4	3	3	3
Others Liabilities ⓘ	2	2	3	2	3	3	3	2	3	6
Total Liabilities ⓘ	55	55	57	56	57	58	61	63	66	69
Fixed Assets
Net Fixed Assets ⓘ +	44	41	43	44	43	41	44	44	49	54
Gross Block	75	75	80	81	82	82	87	90	98	104
Accumulated Depreciation	31	34	37	36	39	41	43	46	49	50
CWIP ⓘ	0	1	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	3	2	2	2	2	2	2	3	3	4
Trade Receivables	1	1	1	1	1	1	1	1	1	1
Cash Equivalents	2	3	4	3	7	10	9	8	7	4
Others Assets ⓘ	5	7	7	6	5	5	5	6	6	6
Total Assets ⓘ	55	55	57	56	57	58	61	63	66	69

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	3	3	6	4	5	3	4	4	6	3
PBT ⓘ	-0	0	2	1	2	2	4	6	4	1
Adjustment ⓘ	4	3	3	2	2	2	2	2	3	3
Changes in Working Capital ⓘ	-1	-0	1	1	1	-1	-1	-2	0	-1
Tax Paid ⓘ	0	-0	-0	-0	-0	-0	-1	-1	-1	-1
Cash Flow From Investing Activity ⓘ +	-1	-1	-4	-4	-1	0	-4	-2	-4	-4
Capex	-1	-1	-4	-5	-1	-0	-5	-3	-5	-5
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	1	1	1	1	1	2	1
Cash Flow From Financing Activity ⓘ +	-1	-0	-2	-1	0	-0	-2	-2	-3	-2
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0	-0	-0	-0	-0	0	0	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	0	-1	0	0	0	-1	-1	-1	-0
Others ⓘ	-0	0	0	-1	0	-0	-0	-1	-2	-1
Net Cash Flow ⓘ	2	2	0	-1	4	3	-1	0	-1	-3

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.2	0.89	3.47	1.41	2.1	3.02	5.56	7.27	4.98	1.24
ROCE (%)	0.27	1.13	3.71	1.66	3.32	4.07	8	10.43	7.19	3.1
Asset Turnover Ratio	0.56	0.62	0.68	0.68	0.72	0.56	0.65	0.76	0.75	0.73
PAT to CFO Conversion(x)	N/A	N/A	3	4	5	1.5	1.33	1	2	3
Working Capital Days
Receivable Days	5.10	6.40	8.70	9	6.40	7.90	6.40	7	9.20	9.50
Inventory Days	34.40	24.60	20.10	21.60	19.20	22	19.20	19.80	22.70	25.90
Payable Days	117.70	87	108.10	110.60	88	107	96.10	81.80	78.70	80.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

87.15

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lotus Eye Hospital And Institute Ltd FAQs

The current trading price of Lotus Eye Hospital on 02-Jul-2026 16:59 is ₹126.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Lotus Eye Hospital stood at ₹263.1 Cr

The latest P/E ratio of Lotus Eye Hospital as of 01-Jul-2026 is 3,247.8.

The latest P/B ratio of Lotus Eye Hospital as of 01-Jul-2026 is 4.37.

The 52-week high of Lotus Eye Hospital is ₹153.0 and the 52-week low is ₹70.08.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lotus Eye Hospital is ₹53.71 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lotus Eye Hospital And Institute Ltd is a below average quality company.

The key valuation ratios of Lotus Eye Hospital And Institute Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Lotus Eye Hospital And Institute Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Lotus Eye Hospital And Institute Ltd

Lotus Eye Care Hospital was originally incorporated as â€˜Kalaivani Health Centre Pvt. Ltd.â€™on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to â€˜Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to â€˜Lotus Eye Care Hospital Limitedâ€™ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.

Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception

Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.

In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.

Lotus has a vision of â€œempowering eyes to illuminate livesâ€. Lotus Eye Care group is marching towards its vision of becoming Indiaâ€™s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.

Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.

Services offered by the company:

Specialty Treatments
Institute of Optometry
Community ophthalmology
Medical Tourism
Eye Bank

Milestones:

1989- Opening of hospital at R.S.Puram, Coimbatore. The same was under management of LVRT from 1992 to 2006.
2002- Opening of hospital at Peelamedu, Coimbatore
2004 -Opening of hospital at Salem
2007- Opening of hospital at Tirupur

Achievements/ recognition:

Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004.
In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
2012 - Life Time Achievement Award to Dr.K.Sundramoorthy by The TamilnaduDr.M.G.R.Medical University.
2014 - For the sake of Governor Award to Dr.K.Sundramoorthy by Rotary International.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Lotus Eye Hospital And Institute Ltd (LOTUSEYE)

Lotus Eye Hospital And Institute Ltd (LOTUSEYE)

Lotus Eye Hospital And Institute stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Lotus Eye Hospital - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lotus Eye Hospital And Institute Ltd FAQs

What is the share price of Lotus Eye Hospital?

What is the market cap of Lotus Eye Hospital?

What is the P/E ratio of Lotus Eye Hospital?

What is the P/B ratio of Lotus Eye Hospital?

What is the 52-week high and low of Lotus Eye Hospital?

What is the TTM revenue of Lotus Eye Hospital?

Is Lotus Eye Hospital And Institute Ltd a good quality company?

Is Lotus Eye Hospital And Institute Ltd undervalued or overvalued?

Is Lotus Eye Hospital And Institute Ltd a good buy now?

About Lotus Eye Hospital And Institute Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.